ABT — ABBOTT LABORATORIES
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1800 ·
Last close
$94.12
Market Cap
$163.94B
52W High
$104.80
52W Low
$81.97
ADV30
13,358,050
Next earnings
2026-07-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 11,164,000,000 | 6,274,000,000 | 1,345,000,000 | 1,077,000,000 | 110,429,000,000 | 6,803,000,000 | 57,728,000,000 |
| Dec 2025 | 11,459,000,000 | 6,537,000,000 | 2,251,000,000 | 1,776,000,000 | 86,713,000,000 | 8,522,000,000 | 33,942,000,000 |
| Sep 2025 | 11,369,000,000 | 6,294,000,000 | 2,057,000,000 | 1,644,000,000 | 84,181,000,000 | 7,511,000,000 | 32,917,000,000 |
| Jun 2025 | 11,142,000,000 | 6,288,000,000 | 2,052,000,000 | 1,779,000,000 | 83,999,000,000 | 6,951,000,000 | 33,170,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$9,464,000,000
Investing CF
$-22,276,000,000
Financing CF
$13,059,000,000
CapEx
$-2,086,000,000
Dividends Paid
$-4,188,000,000
Buybacks
$-793,000,000
EPS Diluted TTM
$3.57
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$49,956,000,000
Inventory
$6,989,000,000
Receivables
$11,224,000,000
ST Investments
$492,000,000
EBIT TTM
$8,673,000,000
Pretax Income TTM
$8,137,000,000
Interest Exp TTM
$536,000,000
Analysts
25
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,134,000,128
EBITDA
$11,744,000,000
Free Cash Flow
$6,341,125,120
Enterprise Value
$191,420,383,232
Total Cash
$7,295,000,064
Total Debt
$34,136,000,512
Shares Out
1,741,813,154
Trailing EPS
$3.57
Book Value
$29.89
ROE
12.3%
ROA
5.6%
Div Yield
2.68%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,328,000,000 | 8,053,000,000 | 6,524,000,000 | 86,713,000,000 | 33,942,000,000 | — | 9,566,000,000 |
| Dec 2024 | 41,950,000,000 | 6,825,000,000 | 13,402,000,000 | 81,414,000,000 | 33,513,000,000 | — | 8,558,000,000 |
| Dec 2023 | 40,109,000,000 | 6,478,000,000 | 5,723,000,000 | 73,214,000,000 | 34,387,000,000 | — | 7,261,000,000 |
| Dec 2022 | 43,653,000,000 | 8,362,000,000 | 6,933,000,000 | 74,438,000,000 | 37,533,000,000 | — | 9,581,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$6.06
Max Pain — expiry 2026-07-10
max pain strike: $91.00 · spot: $94.12 · call oi: 2,942 · put oi: 2,726
Expected Move to 2026-07-10:
±$3.88
(4.12%) —
implied range
$90.25 –
$98.00
· ATM straddle on $94.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NVO | NOVO NORDISK A S | $161.13B | $48.07 | — |
| NONOF | NOVO NORDISK A S | $159.42B | $47.56 | — |
| PFE | PFIZER INC | $138.44B | $24.29 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $124.70B | $491.34 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $117.46B | $57.52 | — |
News headlines (Yahoo Finance, 1h cache)
Update: Market Chatter: Abbott Laboratories Baby Formula Probe Dropped by DOJ After Years-Long Investigation Into Contamination Risks
2026-06-29 14:31 · Yahoo
How Abbott's Largest Segment Is Preparing for the Next Growth Phase
2026-06-29 13:20 · Yahoo
Market Chatter: Abbott Laboratories Baby Formula Probe Dropped by DOJ After Years-Long Investigation Into Contamination Risks
2026-06-29 09:51 · Yahoo
Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth
2026-06-27 15:32 · Yahoo
Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left
2026-06-27 07:08 · Yahoo
Abbott Laboratories' Q2 2026 Earnings: What to Expect
2026-06-26 13:11 · Yahoo
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?
2026-06-26 12:35 · Yahoo
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy
2026-06-25 18:20 · Yahoo
Abbott hosts conference call for second-quarter earnings
2026-06-25 13:00 · Yahoo
How Does Wall Street View Abbott Laboratories (ABT)’s Outlook?
2026-06-25 06:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.